Clinical Outcomes With Bilateral Implantation of Odyssey IOLs
Completed
Conditions studied: Cataract
In brief
This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurement of visual acuities at distance, intermediate, and near.
Key facts
- Study ID
- NCT06550375
- Run by
- Mann Eye Institute
- People needed
- 40
- Starts
- 2024-09-05
- Expected to finish
- 2025-03-26
- Last updated by the study team
- 2026-04-08
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aged 50 years and older who underwent bilateral cataract surgery with Odyssey IOL implantation.
You may not qualify if…
- Significant ocular comorbidities (e.g., macular degeneration, glaucoma).
- < 2 weeks post YAG capsulotomy.
- Best corrected distance visual acuity worse than 20/25.
Where it is running
- Mann Eye Institute — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.